ABT Abbott Laboratories Common Stock
Abbott Laboratories Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Abbott Laboratories, merkezi Abbott Park, Illinois, ABD'de bulunan bir Amerikan tıbbi cihaz ve sağlık şirketidir. Şirket, bilinen ilaçları formüle etmek için 1888'de Şikagolu doktor Wallace Calvin Abbott tarafından kuruldu; Bugün tıbbi cihazlar, teşhisler, markalı jenerik ilaçlar ve beslenme ürünleri satmaktadır. 2013 yılında araştırma tabanlı ilaçları AbbVie Inc.'e ayırdı.
Devamını oku
Abbott Laboratories, merkezi Abbott Park, Illinois, ABD'de bulunan bir Amerikan tıbbi cihaz ve sağlık şirketidir. Şirket, bilinen ilaçları formüle etmek için 1888'de Şikagolu doktor Wallace Calvin Abbott tarafından kuruldu; Bugün tıbbi cihazlar, teşhisler, markalı jenerik ilaçlar ve beslenme ürünleri satmaktadır. 2013 yılında araştırma tabanlı ilaçları AbbVie Inc.'e ayırdı.
Tıbbi cihazlar, teşhis ve beslenme ürünleri bölümlerinde tanınmış ürünler arasında Pedialyte, Similac, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT ve MitraClip bulunmaktadır.
16 Mayıs 2014 tarihinde Abbott'un holding şirketi Kalo Pharma Internacional S.L.'yi (CFR Pharmaceuticals) satın alacağı açıklandı.
Aralık 2014'te şirket, üç ilaç tesisini içeren 410 milyon dolarlık bir anlaşma ile Rus ilaç üreticisi Veropharm'ı (Voronezh) satın aldı. Rusya'da 1.400 kişi çalıştıran Abbott, anlaşma sona erdiğinde ülkede bir üretim varlığı kurmayı planladığını söyledi.
Şubat 2016'da şirket, Alere'i 5,8 milyar dolara satın alacağını açıkladı. Ocak 2017'de Abbott, St. Jude Medical'i 25 milyar dolara satın alacağını açıkladı. 2017 yılında FDA, Abbott'un FreeStyle Libre glikoz izleme sistemini onayladı. Sistem, kendi kendine uygulanan bir sensör aracılığıyla glikoz seviyelerini okumak üzere tasarlanmıştır ve standart parmak çubukları gerektirmez.
3 Ekim 2017'de şirket, Alere'nin satın alınmasıyla birlikte, şirket aynı zamanda en büyük posta siparişi diyabetik tedarikçisi olan yan kuruluşu Arriva Medical'i de satın aldı. Arriva Medical, Abbott'ın satın alınmasından sonra 31 Aralık 2017'de iş kapanışını açıkladı.
Kasım 2018'de Abbott, FreeStyle LibreLink'i başlatmak için FDA izni aldığında Amerika Birleşik Devletleri'nde bir akıllı telefon uygulaması glikoz okuyucusu tanıtan ilk tıbbi cihaz şirketi oldu.
Ocak 2019'da Abbott, mitral kapak hastalığı olan kişiler için daha az invaziv bir yedek kalp kapağı geliştiren Cephea Valve Technologies, Inc.'i satın alma seçeneğini kullanmıştır.
Kaynakça
Dış bağlantılar
Sitesi 18 Ocak 2020 tarihinde Wayback Machine sitesinde arşivlendi.
Abbot Türkiye 3 Mart 2020 tarihinde Wayback Machine sitesinde arşivlendi.
Ayrıca bakınız
Chattem
Selsun Blue
Guidant
Abbott Medical Optics
Abbott Informatics
Tyco International
Thoratec
Getinge Group
Kaynak: Wikipedia, CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
ABT Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
ABT Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
| Ex-tarihi | Miktar |
|---|---|
| 15 Temmuz 2026 | $0,6300 |
| 15 Nisan 2026 | $0,6300 |
| 15 Ocak 2026 | $0,6300 |
| 15 Ekim 2025 | $0,5900 |
| 15 Temmuz 2025 | $0,5900 |
| 15 Nisan 2025 | $0,5900 |
| 15 Ocak 2025 | $0,5900 |
| 15 Ekim 2024 | $0,5500 |
| 15 Temmuz 2024 | $0,5500 |
| 12 Nisan 2024 | $0,5500 |
| 11 Ocak 2024 | $0,5500 |
| 12 Ekim 2023 | $0,5100 |
| 13 Temmuz 2023 | $0,5100 |
| 13 Nisan 2023 | $0,5100 |
| 12 Ocak 2023 | $0,5100 |
| 13 Ekim 2022 | $0,4700 |
| 14 Temmuz 2022 | $0,4700 |
| 13 Nisan 2022 | $0,4700 |
| 13 Ocak 2022 | $0,4700 |
| 14 Ekim 2021 | $0,4500 |
ABT Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
- Güçlü Al 11 33,3%
- Al 13 39,4%
- Tut 9 27,3%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
25 analist · 2026-08-20Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $1.31 | $1.29 | 0.02% |
| 31 Mart 2026 | $1.15 | $1.16 | -0.01% |
| 31 Aralık 2025 | $1.50 | $1.51 | -0.01% |
| 30 Eylül 2025 | $1.30 | $1.31 | -0.01% |
| 30 Haziran 2025 | $1.26 | $1.27 | -0.01% |
| 31 Mart 2025 | $1.09 | $1.08 | 0.01% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
| ISRG | $201.11B | 72.0 | 20.5% | 28.4% | 16.7% | 66.0% |
| SYK | $134.44B | 41.8 | 11.2% | 12.9% | 15.1% | 64.0% |
| BSX | — | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| BDX | — | 25.3 | 8.2% | 7.7% | 6.5% | — |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| GEHC | — | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $44.33B | $41.95B | $40.11B | $43.65B | $43.08B | $34.61B | $31.90B | $30.58B | $27.39B | $20.85B | $20.41B | $20.25B | |
| Cost of Revenue | $19.32B | $18.71B | $17.98B | $19.14B | $18.54B | $15.00B | $13.23B | $12.71B | $12.41B | $9.09B | $8.75B | $9.22B | |
| R&D Expense | $2.94B | $2.84B | $2.74B | $2.89B | $2.74B | $2.42B | $2.44B | $2.30B | $2.26B | · | · | · | |
| SG&A Expense | $12.33B | $11.70B | $10.95B | $11.25B | $11.32B | $9.70B | $9.77B | $9.74B | $9.18B | $6.74B | $6.79B | $6.53B | |
| Operating Expenses | $36.27B | $35.12B | $33.63B | $35.29B | $34.65B | $29.25B | $27.37B | $26.93B | $25.83B | $17.83B | $17.54B | $17.65B | |
| Operating Income | $8.05B | $6.83B | $6.48B | $8.36B | $8.43B | $5.36B | $4.53B | $3.65B | $1.56B | $3.03B | $2.87B | $2.60B | |
| Interest Expense | · | · | $637M | $558M | $533M | $546M | $670M | $826M | $904M | $431M | $163M | $150M | |
| Interest Income | $308M | $344M | $385M | $183M | $43M | $46M | $94M | $105M | $124M | $99M | $105M | $77M | |
| Other Non-op | $548M | $376M | $479M | $321M | $277M | $103M | $191M | $139M | $1.41B | $-786M | $281M | $-14M | |
| Pretax Income | $8.47B | $7.01B | $6.66B | $8.31B | $8.21B | $4.97B | $4.08B | $2.87B | $2.23B | $1.41B | $3.18B | $2.52B | |
| Income Tax | $1.94B | $-6.39B | $941M | $1.37B | $1.14B | $497M | $390M | $539M | $1.88B | $350M | $577M | $797M | |
| Net Income | $6.52B | $13.40B | $5.72B | $6.93B | $7.07B | $4.50B | $3.69B | $2.37B | $477M | $1.40B | $4.42B | $2.28B | |
| EPS (Basic) | $3.73 | $7.67 | $3.28 | $3.94 | $3.97 | $2.52 | $2.07 | $1.34 | $0.27 | $0.94 | $2.94 | $1.50 | |
| EPS (Diluted) | $3.72 | $7.64 | $3.26 | $3.91 | $3.94 | $2.50 | $2.06 | $1.33 | $0.27 | $0.94 | $2.92 | $1.49 | |
| Shares (Basic) | 1,741,000,000 | 1,740,000,000 | 1,740,000,000 | 1,753,000,000 | 1,775,000,000 | 1,773,000,000 | 1,768,000,000 | 1,758,000,000 | 1,740,000,000 | 1,477,000,000 | 1,496,000,000 | 1,516,000,000 | |
| Shares (Diluted) | 1,748,000,000 | 1,748,000,000 | 1,749,000,000 | 1,764,000,000 | 1,789,000,000 | 1,786,000,000 | 1,781,000,000 | 1,770,000,000 | 1,749,000,000 | 1,483,000,000 | 1,506,000,000 | 1,527,000,000 | |
| EBITDA | $8.05B | $6.83B | $6.48B | $8.36B | $8.43B | $5.36B | $4.53B | $3.65B | $1.73B | $3.19B | $2.87B | $2.60B |
Bilanço 27
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8.52B | $7.62B | $6.90B | $9.88B | $9.80B | $6.84B | $3.86B | $3.84B | $9.41B | $18.62B | $5.00B | $4.06B | |
| Short-term Investments | $417M | $351M | $383M | $288M | $450M | $310M | $280M | $242M | $203M | $155M | $1.12B | $397M | |
| Receivables | $7.93B | $6.92B | $6.57B | $6.22B | $6.49B | $6.41B | $5.42B | $5.18B | $5.25B | $3.25B | $3.42B | $3.59B | |
| Inventory | $6.49B | $6.19B | $6.57B | $6.17B | $5.16B | $5.01B | $4.32B | $3.80B | $3.60B | $2.43B | $2.60B | $2.64B | |
| Other Current Assets | · | · | · | · | · | · | · | · | $1.67B | $1.81B | $1.91B | $1.98B | |
| Current Assets | $26.00B | $23.66B | $22.67B | $25.22B | $24.24B | $20.44B | $15.67B | $14.63B | $20.15B | $26.78B | $14.15B | $13.56B | |
| PP&E (Net) | $11.82B | $10.66B | $10.15B | $9.16B | $8.96B | $9.03B | $8.04B | $7.56B | $7.61B | $5.71B | $5.73B | $5.93B | |
| PP&E (Gross) | $25.22B | $22.74B | $21.93B | $20.21B | $19.36B | $18.79B | $16.80B | $15.71B | $15.27B | $12.37B | $12.38B | $12.63B | |
| Accum. Depreciation | $13.41B | $12.08B | $11.78B | $11.05B | $10.40B | $9.76B | $8.76B | $8.14B | $7.66B | $6.66B | $6.65B | $6.70B | |
| Goodwill | $24.04B | $23.11B | $23.68B | $22.80B | $23.23B | $23.74B | $23.20B | $23.25B | $24.02B | $7.68B | $9.64B | $10.07B | |
| Intangibles | $5.53B | $6.65B | $8.81B | $10.45B | $12.74B | $14.78B | $17.02B | $18.94B | $21.47B | $4.54B | $5.56B | $6.20B | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | $2.12B | $3.29B | |
| Total Assets | $86.71B | $81.41B | $73.21B | $74.44B | $75.20B | $72.55B | $67.89B | $67.17B | $76.25B | $52.67B | $41.25B | $41.21B | |
| Short-term Debt | · | · | · | · | $0 | $213M | $201M | $200M | $206M | $1.32B | $3.13B | $4.38B | |
| Current Liabilities | $16.50B | $14.16B | $13.84B | $15.49B | $13.11B | $11.91B | $10.86B | $9.01B | $8.91B | $6.66B | $9.19B | $10.47B | |
| Capital Leases | $931M | $896M | $949M | $943M | $956M | $902M | $755M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $860M | |
| Other Non-current Liabilities | $2.54B | $2.59B | $3.47B | $3.80B | $3.69B | · | · | · | $9.03B | $4.55B | $4.86B | $5.60B | |
| Long-term Debt | $12.93B | $14.12B | $14.68B | $16.77B | $18.05B | $18.53B | $17.94B | $19.37B | $27.72B | $20.68B | $5.87B | $3.45B | |
| Total Debt | $12.93B | $14.12B | $14.68B | $16.77B | $18.05B | $18.75B | $18.14B | $19.57B | $27.92B | $22.01B | $9.00B | $7.84B | |
| Common Stock | $25.53B | $25.15B | $24.87B | $24.71B | $24.47B | $24.14B | $23.85B | $23.51B | $23.21B | $13.03B | $12.73B | $12.38B | |
| Retained Earnings | $49.78B | $47.26B | $37.55B | $35.26B | $31.53B | $27.63B | $25.85B | $24.56B | $23.98B | $25.57B | $25.76B | $22.87B | |
| Treasury Stock | $17.18B | $16.84B | $15.98B | $15.23B | $11.82B | $10.04B | $10.15B | $9.96B | $10.22B | $10.79B | $10.62B | $8.68B | |
| AOCI | $-6.00B | $-7.91B | $-7.84B | $-8.05B | $-8.37B | $-8.95B | $-8.46B | $-7.59B | $-6.06B | $-7.26B | $-6.66B | $-5.05B | |
| Stockholders' Equity | $52.13B | $47.66B | $38.60B | $36.69B | $35.80B | $32.78B | $31.09B | $30.52B | $30.90B | $20.54B | $21.21B | $21.53B | |
| Liabilities + Equity | $86.71B | $81.41B | $73.21B | $74.44B | $75.20B | $72.55B | $67.89B | $67.17B | $76.25B | $52.67B | $41.25B | $41.21B | |
| Shares Outstanding | 1,996,795,525 | 1,991,472,630 | 1,987,883,852 | 1,986,519,278 | 1,985,273,421 | 1,981,156,896 | 1,976,855,085 | 1,971,189,465 | 1,965,908,188 | 1,707,475,455 | 1,702,017,390 | 1,694,929,949 |
Nakit Akışı 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $664M | $673M | $644M | $685M | $640M | $546M | $519M | $477M | $406M | $310M | $292M | $246M | |
| Deferred Tax | $441M | $-7.96B | $-461M | $-659M | $-509M | $-108M | $-491M | $745M | $-890M | $-127M | $293M | $302M | |
| Amort. of Intangibles | $1.68B | $1.88B | $1.97B | $2.01B | $2.05B | $2.13B | $1.94B | $2.18B | $1.98B | $550M | $601M | $630M | |
| Restructuring | · | · | · | · | · | $36M | $66M | $28M | · | · | · | · | |
| Operating Cash Flow | $9.57B | $8.56B | $7.26B | $9.58B | $10.53B | $7.90B | $6.14B | $6.30B | $5.57B | $3.20B | $2.97B | $3.67B | |
| CapEx | $2.17B | $2.21B | $2.20B | $1.78B | $1.89B | $2.18B | $1.64B | $1.39B | $1.14B | $1.12B | $1.11B | $1.08B | |
| Investing Cash Flow | $-2.42B | $-2.34B | $-3.13B | $-1.74B | $-2.01B | $-2.21B | $-1.81B | $-1.36B | $-9.62B | $-248M | $406M | $-202M | |
| Debt Issued | · | · | · | · | $4M | $1.28B | $1.84B | $4.01B | $6.74B | $14.93B | $2.48B | · | |
| Net Debt Issued | · | · | · | · | $-44M | $-52M | $-1.60B | $-8.42B | $-1.91B | $14.92B | $2.43B | $-577M | |
| Stock Repurchased | $893M | $1.29B | $1.23B | $3.79B | $2.30B | $403M | $718M | $238M | $117M | $522M | $2.24B | $2.19B | |
| Net Stock Activity | $-893M | $-1.29B | $-1.23B | $-3.79B | $-2.30B | $-403M | $-718M | $-238M | $-117M | $-522M | $-2.24B | $-2.19B | |
| Dividends Paid | $4.12B | $3.84B | $3.56B | $3.31B | $3.20B | $2.56B | $2.27B | $1.97B | $1.85B | $1.54B | $1.44B | $1.34B | |
| Financing Cash Flow | $-6.31B | $-5.40B | $-7.09B | $-7.64B | $-5.49B | $-2.78B | $-4.29B | $-10.39B | $-5.28B | $11.15B | $-2.24B | $-2.74B | |
| Net Change in Cash | $906M | $720M | $-2.99B | $83M | $2.96B | $2.98B | $16M | $-5.56B | $-9.21B | $13.62B | $938M | $588M | |
| Taxes Paid | $1.93B | $1.72B | $1.48B | $1.86B | $1.94B | $970M | $930M | $740M | $570M | $620M | $631M | · | |
| Free Cash Flow | $7.39B | $6.35B | $5.06B | $7.80B | $8.65B | $5.72B | $4.50B | $4.91B | $4.43B | $2.08B | $1.86B | $2.60B | |
| Levered FCF | · | · | $4.51B | $7.34B | $8.19B | $5.23B | $3.89B | $4.23B | $4.29B | $1.76B | $1.72B | $2.50B |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 18.2% | 16.3% | 16.2% | 19.2% | 19.6% | 15.5% | 14.2% | 11.9% | 6.3% | 15.3% | 14.1% | 12.8% | |
| Net Margin | 14.7% | 31.9% | 14.3% | 15.9% | 16.4% | 13.0% | 11.6% | 7.7% | 1.7% | 6.7% | 21.7% | 11.3% | |
| Pretax Margin | 19.1% | 16.7% | 16.6% | 19.0% | 19.1% | 14.4% | 12.8% | 9.4% | 8.2% | 6.8% | 15.6% | 12.4% | |
| EBITDA Margin | 18.2% | 16.3% | 16.2% | 19.2% | 19.6% | 15.5% | 14.2% | 11.9% | 6.3% | 15.3% | 14.1% | 12.8% | |
| ROA | 7.8% | 17.3% | 7.8% | 9.3% | 9.6% | 6.4% | 5.5% | 3.3% | 0.74% | 3.0% | 10.7% | 5.4% | |
| ROE | 13.1% | 31.1% | 15.2% | 19.1% | 20.6% | 14.1% | 12.0% | 7.7% | 1.8% | 6.7% | 20.7% | 9.8% | |
| ROIC | 9.5% | 21.1% | 10.4% | 13.1% | 13.5% | 9.4% | 8.3% | 5.9% | 0.46% | 5.6% | 7.8% | 6.0% |
Likidite ve Solventlik 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.7 | 1.6 | 1.6 | 1.8 | 1.7 | 1.4 | 1.6 | 2.3 | 4.0 | 1.5 | 1.4 | |
| Quick Ratio | 1.0 | 1.1 | 1.0 | 1.1 | 1.3 | 1.1 | 0.9 | 1.0 | 1.7 | 3.3 | 1.0 | 0.8 | |
| Debt / Equity | 0.2 | 0.3 | 0.4 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.9 | 1.1 | 0.4 | 0.4 | |
| LT Debt / Equity | 0.2 | 0.3 | 0.4 | 0.4 | 0.5 | 0.6 | 0.5 | 0.6 | 0.9 | 1.0 | 0.3 | 0.2 | |
| Interest Coverage | · | · | 10.2 | 15.0 | 15.8 | 9.8 | 6.8 | 4.4 | 1.9 | 7.4 | 17.6 | 17.3 |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | |
| Inventory Turnover | 3.0 | 2.9 | 2.8 | 3.4 | 3.6 | 3.2 | 3.3 | 3.4 | 4.1 | 3.6 | 3.3 | 3.5 | |
| Receivables Turnover | 6.0 | 6.2 | 6.3 | 6.9 | 6.7 | 5.8 | 6.0 | 5.9 | 6.4 | 6.3 | 5.8 | 5.3 |
Büyüme Oranları 10
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 5.7% | 4.6% | -8.1% | 1.3% | 24.5% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 0.51% | -0.88% | 5.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -51.3% | 134.4% | -16.6% | -0.76% | 57.6% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -1.7% | 24.7% | 9.2% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 8.3% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -51.3% | 134.2% | -17.4% | -1.9% | 57.3% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -2.0% | 23.8% | 8.4% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 7.7% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 10.0% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $44.33B | $41.95B | $40.11B | $43.65B | $43.08B | $34.61B | $31.90B | $30.58B | $27.39B | $20.85B | $20.41B | $20.25B | |
| Net Income TTM | $6.52B | $13.40B | $5.72B | $6.93B | $7.07B | $4.50B | $3.69B | $2.37B | $477M | $1.40B | $4.42B | $2.28B | |
| Market Cap | $250.18B | $225.26B | $218.81B | $218.10B | $279.41B | $216.92B | $171.71B | $142.58B | $112.19B | $65.58B | · | · | |
| Enterprise Value | $254.17B | $231.41B | $226.21B | $224.70B | $287.21B | $228.52B | $185.71B | $158.06B | $130.51B | $68.82B | · | · | |
| P/E | 33.7 | 14.8 | 33.8 | 28.1 | 35.7 | 43.8 | 42.2 | 54.4 | 211.4 | 40.9 | 15.4 | 30.2 | |
| P/S | 5.6 | 5.4 | 5.5 | 5.0 | 6.5 | 6.3 | 5.4 | 4.7 | 4.1 | 3.1 | · | · | |
| P/B | 4.8 | 4.7 | 5.7 | 5.9 | 7.8 | 6.6 | 5.5 | 4.7 | 3.6 | 3.2 | · | · | |
| P / Tangible Book | 11.1 | 12.6 | 35.8 | 63.5 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 26.2 | 26.3 | 30.1 | 22.8 | 26.5 | 27.5 | 28.0 | 22.6 | 20.1 | 20.5 | · | · | |
| P / FCF | 33.8 | 35.5 | 43.3 | 27.9 | 32.3 | 37.9 | 38.2 | 29.1 | 25.3 | 31.5 | · | · | |
| EV / EBITDA | 31.6 | 33.9 | 34.9 | 26.9 | 34.1 | 42.7 | 41.0 | 43.3 | 75.6 | 21.6 | · | · | |
| EV / FCF | 34.4 | 36.4 | 44.7 | 28.8 | 33.2 | 39.9 | 41.3 | 32.2 | 29.4 | 33.1 | · | · | |
| EV / Revenue | 5.7 | 5.5 | 5.6 | 5.1 | 6.7 | 6.6 | 5.8 | 5.2 | 4.8 | 3.3 | · | · | |
| Dividend Yield | 1.7% | 1.7% | 1.6% | 1.5% | 1.1% | 1.2% | 1.3% | 1.4% | 1.7% | 2.4% | · | · | |
| Earnings Yield | 3.0% | 6.8% | 3.0% | 3.6% | 2.8% | 2.3% | 2.4% | 1.8% | 0.47% | 2.5% | 6.5% | 3.3% | |
| Payout Ratio | 63.1% | 28.6% | 62.1% | 47.7% | 45.3% | 57.0% | 61.6% | 83.4% | 387.6% | 109.9% | 32.6% | 58.8% | |
| Annual Payout | $4.12B | $3.84B | $3.56B | $3.31B | $3.20B | $2.56B | $2.27B | $1.97B | $1.85B | $1.54B | $1.44B | $1.34B |
Gelir Tablosu 17
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.59B | $11.16B | $11.46B | $11.37B | $11.14B | $10.36B | $10.97B | $10.63B | $10.38B | $9.96B | $10.24B | $10.14B | $9.98B | $9.75B | $10.09B | $10.41B | |
| Cost of Revenue | $5.33B | $4.89B | $4.92B | $5.08B | $4.85B | $4.47B | $4.94B | $4.70B | $4.60B | $4.46B | $4.56B | $4.61B | $4.48B | $4.33B | $4.59B | $4.63B | |
| R&D Expense | $892M | $767M | $735M | $766M | $725M | $716M | $749M | $713M | $698M | $684M | $700M | $672M | $715M | $654M | $725M | $782M | |
| SG&A Expense | $4.03B | $3.74B | $3.13B | $3.05B | $3.09B | $3.06B | $2.91B | $2.90B | $2.94B | $2.96B | $2.72B | $2.72B | $2.74B | $2.76B | $2.97B | $2.73B | |
| Operating Expenses | $10.90B | $9.82B | $9.21B | $9.31B | $9.09B | $8.66B | $9.06B | $8.78B | $8.71B | $8.58B | $8.46B | $8.50B | $8.44B | $8.24B | $8.79B | $8.64B | |
| Operating Income | $1.69B | $1.34B | $2.25B | $2.06B | $2.05B | $1.69B | $1.91B | $1.86B | $1.67B | $1.39B | $1.78B | $1.65B | $1.54B | $1.51B | $1.30B | $1.77B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $141M | · | $166M | $159M | $153M | · | $141M | |
| Interest Income | $52M | $106M | $78M | $77M | $71M | $82M | $91M | $91M | $82M | $80M | $89M | $97M | $98M | $101M | $88M | $55M | |
| Other Non-op | $134M | $159M | $134M | $150M | $137M | $127M | $154M | $121M | $-10M | $111M | $109M | $83M | $176M | $111M | $68M | $93M | |
| Pretax Income | $1.52B | $1.45B | $2.36B | $2.18B | $2.15B | $1.78B | $2.03B | $1.94B | $1.61B | $1.44B | $1.79B | $1.67B | $1.64B | $1.56B | $1.32B | $1.76B | |
| Income Tax | $596M | $372M | $582M | $536M | $371M | $453M | $-7.20B | $294M | $305M | $211M | $201M | $235M | $261M | $244M | $287M | $323M | |
| Net Income | $928M | $1.08B | $1.78B | $1.64B | $1.78B | $1.32B | $9.23B | $1.65B | $1.30B | $1.23B | $1.59B | $1.44B | $1.38B | $1.32B | $1.03B | $1.44B | |
| EPS (Basic) | $0.53 | $0.62 | $1.01 | $0.94 | $1.02 | $0.76 | $5.29 | $0.94 | $0.74 | $0.70 | $0.92 | $0.82 | $0.79 | $0.75 | $0.59 | $0.82 | |
| EPS (Diluted) | $0.53 | $0.61 | $1.01 | $0.94 | $1.01 | $0.76 | $5.26 | $0.94 | $0.74 | $0.70 | $0.91 | $0.82 | $0.78 | $0.75 | $0.59 | $0.81 | |
| Shares (Basic) | 1,740,420,000 | 1,742,480,000 | -3,483,785,000 | 1,742,142,000 | 1,743,437,000 | 1,739,206,000 | -3,482,709,000 | 1,739,466,000 | 1,743,040,000 | 1,740,203,000 | -3,480,797,000 | 1,738,700,000 | 1,740,359,000 | 1,741,738,000 | -3,515,744,000 | 1,752,968,000 | |
| Shares (Diluted) | 1,742,981,000 | 1,747,073,000 | -3,499,416,000 | 1,749,361,000 | 1,750,835,000 | 1,747,220,000 | -3,500,402,000 | 1,747,597,000 | 1,751,153,000 | 1,749,652,000 | -3,501,252,000 | 1,748,289,000 | 1,750,248,000 | 1,751,715,000 | -3,539,658,000 | 1,763,653,000 | |
| EBITDA | $1.69B | $1.34B | · | $2.06B | $2.05B | $1.69B | · | $1.86B | $1.67B | $1.39B | · | $1.65B | $1.54B | $1.51B | · | $1.77B |
Bilanço 23
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5.10B | $6.80B | $8.52B | $7.51B | $6.95B | $6.53B | $7.62B | $7.56B | $6.99B | $6.28B | · | $6.71B | $7.83B | $9.16B | · | $9.59B | |
| Short-term Investments | $499M | $492M | $417M | $222M | $331M | $312M | $351M | $230M | $232M | $367M | · | $338M | $320M | $371M | · | $313M | |
| Receivables | $8.60B | $8.21B | $7.93B | $8.14B | $7.97B | $7.33B | $6.92B | $7.05B | $6.85B | $6.61B | · | $6.50B | $6.17B | $6.02B | · | $6.41B | |
| Inventory | $7.32B | $6.99B | $6.49B | $6.71B | $6.95B | $6.64B | $6.19B | $6.81B | $6.81B | $6.83B | · | $6.65B | $6.87B | $6.67B | · | $5.73B | |
| Current Assets | $24.52B | $25.51B | $26.00B | $24.84B | $24.47B | $23.15B | $23.66B | $23.80B | $23.12B | $22.38B | · | $22.66B | $23.50B | $24.38B | · | $24.84B | |
| PP&E (Net) | $12.81B | $12.38B | $11.82B | $11.50B | $11.39B | $10.93B | $10.66B | $10.62B | $10.23B | $10.11B | · | $9.55B | $9.45B | $9.28B | · | $8.69B | |
| PP&E (Gross) | $26.47B | $25.74B | $25.22B | $24.82B | $24.47B | $23.42B | $22.74B | $22.86B | $22.06B | $22.05B | · | $21.11B | $20.93B | $20.61B | · | $19.31B | |
| Accum. Depreciation | $13.66B | $13.36B | $13.41B | $13.31B | $13.08B | $12.49B | $12.08B | $12.24B | $11.83B | $11.95B | · | $11.56B | $11.48B | $11.32B | · | $10.62B | |
| Goodwill | $35.24B | $35.22B | $24.04B | $23.97B | $23.95B | $23.36B | $23.11B | $23.66B | $23.31B | $23.38B | · | $23.28B | $23.26B | $22.93B | · | $22.28B | |
| Intangibles | $17.21B | $17.88B | $5.53B | $5.60B | $5.92B | $6.26B | $6.65B | $7.35B | $7.83B | $8.30B | · | $9.28B | $9.83B | $10.01B | · | $10.85B | |
| Total Assets | $109.22B | $110.43B | $86.71B | $84.18B | $84.00B | $81.45B | $81.41B | $74.36B | $73.02B | $72.47B | · | $72.09B | $73.35B | $73.79B | · | $72.80B | |
| Current Liabilities | $17.81B | $18.38B | $16.50B | $14.58B | $13.44B | $13.00B | $14.16B | $14.90B | $13.76B | $14.02B | · | $13.04B | $14.35B | $14.53B | · | $13.37B | |
| Capital Leases | · | · | $931M | · | · | · | $896M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | $2.54B | · | · | · | $2.59B | · | · | · | · | · | · | · | · | · | |
| Long-term Debt | $32.61B | $34.05B | $12.93B | $12.94B | $13.44B | $13.24B | $14.12B | $14.98B | $14.75B | $14.59B | · | $15.53B | $16.85B | $16.90B | · | $16.41B | |
| Total Debt | $32.61B | $34.05B | · | $12.94B | $13.44B | $13.24B | · | $14.98B | $14.75B | $14.59B | · | $15.53B | $16.85B | $16.90B | · | $16.41B | |
| Common Stock | $25.50B | $25.35B | $25.53B | $25.41B | $25.28B | $25.12B | $25.15B | $25.02B | $24.86B | $24.73B | · | $24.73B | $24.61B | $24.49B | · | $24.56B | |
| Retained Earnings | $49.79B | $49.96B | $49.78B | $49.10B | $48.47B | $47.72B | $47.26B | $39.06B | $38.35B | $38.01B | · | $36.92B | $36.35B | $35.87B | · | $35.12B | |
| Treasury Stock | $17.97B | $16.93B | $17.18B | $16.88B | $16.61B | $16.61B | $16.84B | $16.48B | $15.76B | $15.76B | · | $15.69B | $15.72B | $15.31B | · | $14.55B | |
| AOCI | $-6.21B | $-6.31B | $-6.00B | $-6.68B | $-6.58B | $-7.42B | $-7.91B | $-7.80B | $-8.13B | $-8.17B | $-7.84B | $-8.48B | $-8.07B | $-8.04B | $-8.05B | $-9.45B | |
| Stockholders' Equity | $51.11B | $52.06B | $52.13B | $50.95B | $50.56B | $48.81B | $47.66B | $39.80B | $39.32B | $38.81B | · | $37.48B | $37.17B | $37.01B | · | $35.67B | |
| Liabilities + Equity | $109.22B | $110.43B | $86.71B | $84.18B | $84.00B | $81.45B | $81.41B | $74.36B | $73.02B | $72.47B | · | $72.09B | $73.35B | $73.79B | · | $72.80B | |
| Shares Outstanding | 1,998,291,279 | 1,998,233,756 | 1,996,795,525 | 1,996,743,794 | 1,996,448,469 | 1,995,858,606 | 1,991,472,630 | 1,991,051,414 | 1,990,029,292 | 1,989,789,999 | 1,987,883,852 | 1,987,305,154 | 1,987,181,491 | 1,986,904,170 | 1,986,519,278 | 1,985,919,440 |
Nakit Akışı 14
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $168M | $317M | $113M | $120M | $142M | $289M | $111M | $117M | $141M | $304M | $114M | $117M | $132M | $281M | $115M | $123M | |
| Amort. of Intangibles | $658M | $422M | $422M | $420M | $420M | $420M | $465M | $470M | $471M | $472M | $481M | $496M | $498M | $491M | $496M | $498M | |
| Operating Cash Flow | $2.49B | $1.31B | $3.31B | $2.79B | $2.05B | $1.42B | $2.87B | $2.71B | $1.96B | $1.02B | $3.04B | $1.88B | $1.20B | $1.14B | $2.33B | $2.78B | |
| CapEx | $497M | $399M | $689M | $496M | $502M | $484M | $720M | $556M | $533M | $398M | $755M | $560M | $507M | $380M | $610M | $467M | |
| Investing Cash Flow | $-673M | $-20.32B | $-913M | $-457M | $-582M | $-470M | $-866M | $-594M | $-453M | $-425M | $-824M | $-634M | $-1.21B | $-462M | $-632M | $-484M | |
| Debt Issued | $-33M | $19.86B | · | $0 | $2M | $1M | · | $1M | $221M | $0 | · | $0 | · | · | · | $1M | |
| Net Debt Issued | · | $18.44B | · | · | · | $-1.00B | · | · | · | · | · | · | · | $0 | · | · | |
| Stock Repurchased | $1.04B | $180M | $302M | $305M | $6M | $280M | $315M | $751M | $3M | $226M | $259M | $2M | $426M | $540M | $685M | $798M | |
| Net Stock Activity | · | $-180M | · | · | · | $-280M | · | · | · | $-226M | · | · | · | $-540M | · | · | |
| Dividends Paid | $1.10B | $1.10B | $1.03B | $1.03B | $1.03B | $1.03B | $958M | $960M | $961M | $957M | $888M | $888M | $890M | $890M | $823M | $826M | |
| Financing Cash Flow | $-3.52B | $17.31B | $-1.40B | $-1.76B | $-1.10B | $-2.06B | $-1.86B | $-1.58B | $-791M | $-1.18B | $-2.05B | $-2.34B | $-1.29B | $-1.41B | $-1.46B | $-1.54B | |
| Net Change in Cash | $-1.70B | $-1.72B | $1.01B | $560M | $419M | $-1.08B | $58M | $571M | $703M | $-612M | $187M | $-1.13B | $-1.33B | $-721M | $288M | $657M | |
| Free Cash Flow | · | $916M | · | · | · | $933M | · | · | · | $627M | · | · | · | $763M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $507M | · | · | · | $634M | · | · |
Kârlılık 7
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 13.4% | 12.0% | · | 18.1% | 18.4% | 16.3% | · | 17.5% | 16.1% | 13.9% | · | 16.2% | 15.4% | 15.5% | · | 17.0% | |
| Net Margin | 7.4% | 9.7% | · | 14.5% | 16.0% | 12.8% | · | 15.5% | 12.6% | 12.3% | · | 14.2% | 13.8% | 13.5% | · | 13.8% | |
| Pretax Margin | 12.1% | 13.0% | · | 19.2% | 19.3% | 17.2% | · | 18.2% | 15.5% | 14.4% | · | 16.5% | 16.4% | 16.0% | · | 16.9% | |
| EBITDA Margin | 13.4% | 12.0% | · | 18.1% | 18.4% | 16.3% | · | 17.5% | 16.1% | 13.9% | · | 16.2% | 15.4% | 15.5% | · | 17.0% | |
| ROA | 0.96% | 1.1% | · | 2.1% | 2.3% | 1.7% | · | 2.2% | 1.8% | 1.7% | · | 2.0% | 1.9% | 1.8% | · | 2.0% | |
| ROE | 1.8% | 2.1% | · | 3.6% | 4.0% | 3.0% | · | 4.3% | 3.4% | 3.2% | · | 3.9% | 3.7% | 3.6% | · | 4.1% | |
| ROIC | 1.2% | 1.2% | · | 2.4% | 2.6% | 2.0% | · | 2.9% | 2.5% | 2.2% | · | 2.7% | 2.4% | 2.4% | · | 2.8% |
Likidite ve Solventlik 5
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | · | 1.7 | 1.8 | 1.8 | · | 1.6 | 1.7 | 1.6 | · | 1.7 | 1.6 | 1.7 | · | 1.9 | |
| Quick Ratio | 0.8 | 0.8 | · | 1.1 | 1.1 | 1.1 | · | 1.0 | 1.0 | 0.9 | · | 1.0 | 1.0 | 1.1 | · | 1.2 | |
| Debt / Equity | 0.6 | 0.7 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | |
| LT Debt / Equity | 0.6 | 0.6 | · | 0.2 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 9.8 | · | 9.9 | 9.7 | 9.9 | · | 12.6 |
Verimlilik 3
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.7 | 0.7 | · | 0.8 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.8 | |
| Receivables Turnover | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.6 | · | 1.6 | 1.5 | 1.5 | · | 1.6 |
Değerleme (TTM) 15
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $46.27B | $44.03B | · | $43.50B | $42.51B | $41.33B | · | $41.12B | $40.46B | $39.83B | · | $40.28B | $41.39B | $43.31B | · | $44.49B | |
| Net Income TTM | $5.43B | $5.83B | · | $6.39B | $6.05B | $5.50B | · | $5.61B | $5.34B | $5.35B | · | $5.56B | $6.15B | $7.22B | · | $8.00B | |
| Market Cap | $181.32B | $205.16B | · | $267.44B | $271.54B | $264.75B | · | $227.00B | $206.78B | $226.16B | · | $192.47B | $216.64B | $201.19B | · | $192.16B | |
| Enterprise Value | $208.33B | $231.91B | · | $272.65B | $277.69B | $271.15B | · | $234.19B | $214.32B | $234.09B | · | $200.95B | $225.33B | $208.56B | · | $198.66B | |
| P/E | 29.4 | 30.9 | · | 36.7 | 39.4 | 42.2 | · | 35.6 | 34.2 | 37.3 | · | 30.6 | 31.3 | 24.9 | · | 21.6 | |
| P/S | 3.9 | 4.7 | · | 6.1 | 6.4 | 6.4 | · | 5.5 | 5.1 | 5.7 | · | 4.8 | 5.2 | 4.6 | · | 4.3 | |
| P/B | 3.5 | 3.9 | · | 5.2 | 5.4 | 5.4 | · | 5.7 | 5.3 | 5.8 | · | 5.1 | 5.8 | 5.4 | · | 5.4 | |
| P / Tangible Book | · | · | · | 12.5 | 13.1 | 13.8 | · | 25.8 | 25.3 | 31.7 | · | 39.1 | 53.1 | 49.3 | · | 75.6 | |
| P / Cash Flow | · | 156.0 | · | · | · | 186.8 | · | · | · | 220.6 | · | · | · | 176.0 | · | · | |
| P / FCF | · | 224.0 | · | · | · | 283.8 | · | · | · | 360.7 | · | · | · | 263.7 | · | · | |
| EV / EBITDA | 123.1 | 172.4 | · | 132.5 | 135.3 | 160.2 | · | 126.0 | 128.4 | 168.9 | · | 122.0 | 146.1 | 138.2 | · | 112.2 | |
| EV / FCF | · | 253.2 | · | · | · | 290.6 | · | · | · | 373.4 | · | · | · | 273.3 | · | · | |
| EV / Revenue | 4.5 | 5.3 | · | 6.3 | 6.5 | 6.6 | · | 5.7 | 5.3 | 5.9 | · | 5.0 | 5.4 | 4.8 | · | 4.5 | |
| Earnings Yield | 3.4% | 3.2% | · | 2.7% | 2.5% | 2.4% | · | 2.8% | 2.9% | 2.7% | · | 3.3% | 3.2% | 4.0% | · | 4.6% | |
| Payout Ratio | · | 102.0% | · | · | · | 77.4% | · | · | · | 78.1% | · | · | · | 67.5% | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $44.33B | $41.95B | $40.11B | $43.65B | $43.08B |
| Faaliyet Kâr Marjı % | 18.2% | 16.3% | 16.2% | 19.2% | 19.6% |
| Net Gelir | $6.52B | $13.40B | $5.72B | $6.93B | $7.07B |
| Seyreltilmiş Hisse Başı Kâr | $3.72 | $7.64 | $3.26 | $3.91 | $3.94 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.2 | 0.3 | 0.4 | 0.5 | 0.5 |
| Cari Oran | 1.6 | 1.7 | 1.6 | 1.6 | 1.8 |
| Cari Oran | 1.0 | 1.1 | 1.0 | 1.1 | 1.3 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $7.39B | $6.35B | $5.06B | $7.80B | $8.65B |
Son Haberler Bu şirketten bahseden son manşetler
- Abbott raises 2026 profit forecast on strength in diagnostics, heart devices
- Why Abbott Stock Jumped Today
- Is Abbott (ABT) the Best Longevity Stock to Buy Now?
- This is Why Abbott Laboratories (ABT) is One of the Best Deep Value Stock to Invest In
- 2 Yılda Bir Al ve Sonsuza Dek Tutulacak Temettü Hissesi
- Abbott Hissesi 52 Haftanın Düşük Seviyesinde İşlem Görüyor Ancak Bu Mavi Çip Temettü Ödeyicisinin Hisselerini İçeriden Öğrenenler Topluyor
- May'da Güvenilir Temettü Geliri mi İstiyorsunuz? Bu 2 Hisse Senedi Sunuyor
- Bu On Yılın En Yüksek Getirisini Sunan Bu Temettü Kralı Alınmalı Mı?
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 3.307 dosya · $77.5B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 167 (-58 önceki Ç'ye göre) | 264 (-26 önceki Ç'ye göre) | 1.074 (-57 önceki Ç'ye göre) | 1.358 (-40 önceki Ç'ye göre) | -26.3M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $10.321.765.196 | 113.750.994 | 13,32% | Hisse senetleri |
| STATE STREET CORP | $7.343.246.473 | 80.926.234 | 9,48% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $4.447.881.161 | 49.017.866 | 5,74% | Hisse senetleri |
| Capital Research Global Investors | $3.349.205.208 | 36.908.990 | 4,32% | Hisse senetleri |
| Capital International Investors | $3.146.147.651 | 34.654.113 | 4,06% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $3.021.806.516 | 33.484.908 | 3,90% | Hisse senetleri |
| NORGES BANK | $2.119.224.624 | 23.354.911 | 2,73% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $988.809.932 | 10.897.178 | 1,28% | Hisse senetleri |
| FLOSSBACH VON STORCH SE | $902.938.133 | 9.950.828 | 1,17% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $887.350.453 | 9.779.044 | 1,14% | Hisse senetleri |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | $873.572.128 | 9.627.200 | 1,13% | Hisse senetleri |
| Grantham, Mayo, Van Otterloo & Co. LLC | $797.974.712 | 8.794.077 | 1,03% | Hisse senetleri |
| JANUS HENDERSON GROUP PLC | $780.800.730 | 7.604.955 | 1,01% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $737.381.823 | 8.126.315 | 0,95% | Hisse senetleri |
| CITADEL ADVISORS LLC | $732.793.646 | 8.075.751 | 0,95% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $724.904.438 | 7.988.808 | 0,94% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $694.247.236 | 7.650.948 | 0,90% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $579.394.142 | 6.385.212 | 0,75% | Hisse senetleri |
| BlackRock, Inc. | $551.881.406 | 6.082.008 | 0,71% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $547.727.798 | 6.035.539 | 0,71% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $535.831.639 | 5.905.132 | 0,69% | Hisse senetleri |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $487.309.824 | 5.370.397 | 0,63% | Hisse senetleri |
| FMR LLC | $477.936.254 | 5.267.096 | 0,62% | Hisse senetleri |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $447.962.873 | 4.936.774 | 0,58% | Hisse senetleri |
| Swiss National Bank | $445.749.361 | 4.912.380 | 0,58% | Hisse senetleri |
| Mitsubishi UFJ Asset Management Co., Ltd. | $390.471.098 | 4.303.186 | 0,50% | Hisse senetleri |
| National Pension Service | $381.876.296 | 4.208.467 | 0,49% | Hisse senetleri |
| ENVESTNET ASSET MANAGEMENT INC | $359.002.790 | 3.956.395 | 0,46% | Hisse senetleri |
| Legal & General Group Plc | $356.621.537 | 3.930.147 | 0,46% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $356.401.041 | 3.927.717 | 0,46% | Hisse senetleri |
| Sumitomo Mitsui Trust Group, Inc. | $356.221.103 | 3.925.734 | 0,46% | Hisse senetleri |
| VANGUARD ASSET MANAGEMENT, Ltd | $355.855.239 | 3.921.702 | 0,46% | Hisse senetleri |
| VANGUARD GROUP INC | $352.398.046 | 2.812.659 | 0,45% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $326.663.456 | 3.599.994 | 0,42% | Hisse senetleri |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $324.048.420 | 3.571.175 | 0,42% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $307.912.464 | 2.999.050 | 0,40% | Hisse senetleri |
| UBS Group AG | $302.485.873 | 3.333.545 | 0,39% | Hisse senetleri |
| PRINCIPAL FINANCIAL GROUP INC | $295.969.379 | 3.261.730 | 0,38% | Hisse senetleri |
| Assenagon Asset Management S.A. | $292.053.223 | 3.218.572 | 0,38% | Hisse senetleri |
| JARISLOWSKY, FRASER Ltd | $289.054.440 | 2.158.089 | 0,37% | Hisse senetleri |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | $283.562.500 | 3.125.000 | 0,37% | Hisse senetleri |
| Rathbones Group PLC | $279.003.540 | 3.074.758 | 0,36% | Hisse senetleri |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $274.648.102 | 2.675.057 | 0,35% | Hisse senetleri |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $262.660.558 | 2.558.299 | 0,34% | Hisse senetleri |
| STOREBRAND ASSET MANAGEMENT AS | $259.462.863 | 2.859.410 | 0,33% | Hisse senetleri |
| PNC Financial Services Group, Inc. | $257.810.942 | 2.841.205 | 0,33% | Hisse senetleri |
| RHUMBLINE ADVISERS | $255.936.973 | 2.820.543 | 0,33% | Hisse senetleri |
| UBS Group AG | $250.750.916 | 2.763.400 | 0,32% | Satım opsiyonu |
| RAYMOND JAMES FINANCIAL INC | $245.980.061 | 2.710.823 | 0,32% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $239.769.108 | 2.642.375 | 0,31% | Hisse senetleri |
| 1832 Asset Management L.P. | $237.351.068 | 2.615.727 | 0,31% | Hisse senetleri |
| CITADEL ADVISORS LLC | $234.272.532 | 2.581.800 | 0,30% | Alım opsiyonu |
| CANADA PENSION PLAN INVESTMENT BOARD | $230.891.469 | 2.544.539 | 0,30% | Hisse senetleri |
| Holocene Advisors, LP | $226.003.396 | 2.490.670 | 0,29% | Hisse senetleri |
| Ninety One UK Ltd | $225.389.076 | 2.483.900 | 0,29% | Hisse senetleri |
| NEUBERGER BERMAN GROUP LLC | $223.999.839 | 2.467.027 | 0,29% | Hisse senetleri |
| Ensign Peak Advisors, Inc | $216.085.151 | 2.381.366 | 0,28% | Hisse senetleri |
| JANE STREET GROUP, LLC | $213.973.994 | 2.358.100 | 0,28% | Alım opsiyonu |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $211.616.115 | 2.332.115 | 0,27% | Hisse senetleri |
| LPL Financial LLC | $205.718.613 | 2.267.122 | 0,27% | Hisse senetleri |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $201.807.847 | 2.224.023 | 0,26% | Hisse senetleri |
| BARCLAYS PLC | $200.112.461 | 2.205.339 | 0,26% | Hisse senetleri |
| Qube Research & Technologies Ltd | $194.357.367 | 2.141.915 | 0,25% | Hisse senetleri |
| California Public Employees Retirement System | $194.024.624 | 2.138.248 | 0,25% | Hisse senetleri |
| Nuveen Asset Management, LLC | $192.921.092 | 1.705.606 | 0,25% | Hisse senetleri |
| PeakShares LLC | $184.202.000 | 2.030 | 0,24% | Hisse senetleri |
| Fayez Sarofim & Co | $183.924.904 | 2.026.944 | 0,24% | Hisse senetleri |
| ProShare Advisors LLC | $182.849.174 | 2.015.089 | 0,24% | Hisse senetleri |
| Mirae Asset Global Investments Co., Ltd. | $171.498.419 | 1.889.998 | 0,22% | Hisse senetleri |
| NEW YORK STATE COMMON RETIREMENT FUND | $171.110.051 | 1.885.718 | 0,22% | Hisse senetleri |
| US BANCORP \DE\ | $169.625.636 | 1.869.359 | 0,22% | Hisse senetleri |
| DAVENPORT & Co LLC | $166.731.901 | 1.827.013 | 0,22% | Hisse senetleri |
| Nuveen, LLC | $165.441.322 | 1.823.246 | 0,21% | Hisse senetleri |
| Focus Partners Wealth | $159.171.295 | 1.753.727 | 0,21% | Hisse senetleri |
| LOCUST WOOD CAPITAL ADVISERS, LLC | $156.227.543 | 1.721.705 | 0,20% | Hisse senetleri |
| FIFTH THIRD BANCORP | $155.739.304 | 1.716.325 | 0,20% | Hisse senetleri |
| Alecta Tjanstepension Omsesidigt | $145.922.256 | 1.609.200 | 0,19% | Hisse senetleri |
| Hudson Bay Capital Management LP | $145.184.000 | 1.600.000 | 0,19% | Hisse senetleri |
| Mizuho Markets Cayman LP | $144.086.409 | 1.587.904 | 0,19% | Hisse senetleri |
| HighTower Advisors, LLC | $143.884.700 | 1.585.681 | 0,19% | Hisse senetleri |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | $141.332.725 | 1.557.555 | 0,18% | Hisse senetleri |
| Point72 Asset Management, L.P. | $140.822.037 | 1.551.929 | 0,18% | Hisse senetleri |
| MACKENZIE FINANCIAL CORP | $140.782.112 | 1.551.489 | 0,18% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $139.367.566 | 1.535.900 | 0,18% | Alım opsiyonu |
| AVIVA PLC | $138.734.382 | 1.528.922 | 0,18% | Hisse senetleri |
| Hudson Bay Capital Management LP | $136.110.000 | 1.500.000 | 0,18% | Satım opsiyonu |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $134.754.435 | 1.485.061 | 0,17% | Hisse senetleri |
| EVERETT HARRIS & CO /CA/ | $131.785.524 | 1.452.342 | 0,17% | Hisse senetleri |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $130.414.419 | 1.432.081 | 0,17% | Hisse senetleri |
| TD Asset Management Inc | $129.183.362 | 1.423.665 | 0,17% | Hisse senetleri |
| Vestal Point Capital, LP | $127.036.000 | 1.400.000 | 0,16% | Hisse senetleri |
| Bank Julius Baer & Co. Ltd, Zurich | $126.054.316 | 1.387.458 | 0,16% | Hisse senetleri |
| Freestone Grove Partners LP | $124.572.046 | 1.372.846 | 0,16% | Hisse senetleri |
| Public Sector Pension Investment Board | $124.551.992 | 1.372.625 | 0,16% | Hisse senetleri |
| Eurizon Capital SGR S.p.A. | $121.802.182 | 1.335.277 | 0,16% | Hisse senetleri |
| M&G PLC | $120.614.949 | 1.325.439 | 0,16% | Hisse senetleri |
| ING GROEP NV | $119.814.457 | 1.320.415 | 0,15% | Hisse senetleri |
| MARSHALL WACE, LLP | $119.044.891 | 1.311.934 | 0,15% | Hisse senetleri |
| Baird Financial Group, Inc. | $116.820.060 | 1.287.415 | 0,15% | Hisse senetleri |
| PRUDENTIAL FINANCIAL INC | $115.655.480 | 1.274.581 | 0,15% | Hisse senetleri |
Şirket yöneticileri 110 içeriden öğrenenler · 75 yöneticiler · 32 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Robert B Ford | CHAIRMAN AND CEO | 28 Şubat 2025 F | 253.305 | 0 | 0 | $0 |
| Philip P Boudreau | EVP AND CFO | 01 Eylül 2025 F | 50.616 | 0 | 0 | $0 |
| Brian B Yoor | Executive Vice President & CFO | 28 Şubat 2020 F | 114.099 | 0 | 0 | $0 |
| Jeffrey M Leiden | President and COO | 24 Mart 2006 D | 209.401 | 0 | 0 | $0 |
| Elizabeth C. Cushman | EVP, GC AND SECRETARY | 27 Haziran 2026 F | 38.013 | 0 | 0 | $0 |
| John A. Mccoy JR. | VICE PRESIDENT AND CONTROLLER | 01 Eylül 2025 F | 20.982 | 0 | 0 | $0 |
| Lisa D Earnhardt | EVP AND GROUP PRESIDENT | 07 Mart 2025 M | 71.928 | 0 | 0 | $0 |
| Eric Shroff | Senior Vice President | 03 Mart 2025 S | 31.970 | 0 | 0 | $0 |
| Mary K Moreland | EXECUTIVE VICE PRESIDENT | 03 Mart 2025 S | 95.583 | 0 | 0 | $0 |
| Andrea F Wainer | RETIRED EVP | 03 Mart 2025 S | 74.381 | 0 | 0 | $0 |
| Daniel Gesua Sive Salvadori | EVP AND GROUP PRESIDENT | 28 Şubat 2025 F | 133.769 | 0 | 0 | $0 |
| Hubert L Allen | EXECUTIVE VICE PRESIDENT, GC | 28 Şubat 2025 F | 191.899 | 0 | 0 | $0 |
| Robert E Funck | EXECUTIVE VICE PRESIDENT | 10 Mayıs 2024 M | 211.341 | 0 | 0 | $0 |
| Julie L. Tyler | SENIOR VICE PRESIDENT | 01 Mart 2023 S | 39.162 | 0 | 0 | $0 |
| Gregory A Ahlberg | SENIOR VICE PRESIDENT | 01 Mart 2023 S | 38.420 | 0 | 0 | $0 |
| John F Ginascol | EXECUTIVE VICE PRESIDENT | 01 Mart 2023 S | 118.380 | 0 | 0 | $0 |
| Joseph J Manning | EXECUTIVE VICE PRESIDENT | 01 Mart 2023 S | 62.323 | 0 | 0 | $0 |
| Jared Watkin | SENIOR VICE PRESIDENT | 01 Mart 2023 S | 71.366 | 0 | 0 | $0 |
| Randel William Woodgrift | SENIOR VICE PRESIDENT | 01 Mart 2023 S | 52.203 | 0 | 0 | $0 |
| DALE MICHAEL D | SENIOR VICE PRESIDENT | 01 Mart 2023 S | 45.133 | 0 | 0 | $0 |
| Fernando Mateus | SENIOR VICE PRESIDENT | 28 Şubat 2023 F | 22.857 | 0 | 0 | $0 |
| Christopher J. Calamari | SENIOR VICE PRESIDENT | 28 Şubat 2023 F | 32.822 | 0 | 0 | $0 |
| Sammy Karam | SENIOR VICE PRESIDENT | 28 Şubat 2023 F | 38.092 | 0 | 0 | $0 |
| Alejandro D Wellisch | SENIOR VICE PRESIDENT | 28 Şubat 2023 F | 46.752 | 0 | 0 | $0 |
| Michael J Pederson | SENIOR VICE PRESIDENT | 28 Şubat 2023 F | 63.156 | 0 | 0 | $0 |
| John M Capek | EXECUTIVE VICE PRESIDENT | 28 Şubat 2023 F | 339.443 | 0 | 0 | $0 |
| Andrew H Lane | EXECUTIVE VICE PRESIDENT | 15 Kasım 2021 S | 76.087 | 0 | 0 | $0 |
| Miles D White | EXECUTIVE CHAIRMAN | 12 Kasım 2021 G | 3.092.852 | 0 | 0 | $0 |
| Roger Bird | SENIOR VICE PRESIDENT | 27 Nisan 2021 S | 51.083 | 0 | 0 | $0 |
| Christopher J Scoggins | SENIOR VICE PRESIDENT | 01 Nisan 2021 F | 46.121 | 0 | 0 | $0 |
| Charles Brynelsen | SENIOR VICE PRESIDENT | 01 Mart 2021 S | 43.550 | 0 | 0 | $0 |
| Jaime Contreras | Senior Vice President | 21 Nisan 2020 M | 62.205 | 0 | 0 | $0 |
| Brian J Blaser | Executive Vice President | 23 Mayıs 2019 M | 130.745 | 0 | 0 | $0 |
| Stephen R Fussell | Executive Vice President | 23 Nisan 2019 M | 169.935 | 0 | 0 | $0 |
| Sharon J Bracken | Senior Vice President | 31 Mart 2019 D | 5.936 | 0 | 0 | $0 |
| Sean Shrimpton | Senior Vice President | 31 Aralık 2018 F | 16.165 | 0 | 0 | $0 |
| Eric S Fain | Senior Vice President | 21 Temmuz 2017 D | 493.961 | 0 | 0 | $0 |
| Michael T Rousseau | Pres., Cardiovas. & Neuromod. | 07 Temmuz 2017 F | 183.116 | 0 | 0 | $0 |
| Heather L Mason | Executive Vice President | 01 Temmuz 2017 F | 59.064 | 0 | 0 | $0 |
| Michael J Warmuth | Executive Vice President | 01 Mart 2017 S | 56.508 | 0 | 0 | $0 |
| Jean-Yves Pavee | Senior Vice President | 01 Temmuz 2016 F | 36.861 | 0 | 0 | $0 |
| Richard W Ashley | Executive Vice President | 29 Şubat 2016 S | 354.517 | 0 | 0 | $0 |
| Thomas G Frinzi | Senior Vice President | 19 Şubat 2016 A | 31.921 | 0 | 0 | $0 |
| Charles D Foltz | Senior Vice President | 01 Nisan 2015 F | 93.333 | 0 | 0 | $0 |
| Scott J. White | Senior Vice President | 26 Mart 2015 M | 95.719 | 0 | 0 | $0 |
| Georges H. Devos | Senior Vice President | 27 Şubat 2015 A | 12.129 | 0 | 0 | $0 |
| Murthy V Simhambhatla | Senior Vice President | 27 Şubat 2015 F | 57.575 | 0 | 0 | $0 |
| John C Landgraf | Executive Vice President | 27 Şubat 2015 F | 108.972 | 0 | 0 | $0 |
| Katherine C. Doyle | Senior Vice President | 15 Nisan 2014 S | 43.474 | 0 | 0 | $0 |
| David A. Forrest | Senior Vice President | 17 Eylül 2013 F | 42.013 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 11 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| [Entities Only] Abbott Laboratories (, Abbott Products, Abbott Investments Luxembourg S.à r.l. ×6 başvurular | 24 Mart 2017 | — | İlk başvuru | — | SEC |
| Abbott Laboratories, Amber Acquisition Inc. ×13 başvurular | 21 Nisan 2010 | — | İlk başvuru | M&A / satış | SEC |
| Abbott Laboratories IRS Identification No. ×11 başvurular | 16 Aralık 2004 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi | 22 Ocak 2004 | — | İlk başvuru | M&A / satış | SEC |
| S. OR | 08 Ağustos 2002 | — | İlk başvuru | — | SEC |
| Abbott Laboratories ( | 07 Mart 2002 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi | 01 Kasım 2001 | — | İlk başvuru | M&A / satış | SEC |
| Açıklanmayan raporlama kişisi | 24 Mayıs 2001 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi | 17 Nisan 2001 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi | 07 Mart 2001 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi | 16 Şubat 2001 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 227 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IHI · iShares Trust | 19,02% | 5.737.319 SH | 21 Ağustos 2026 | Günlük |
| PJP · Invesco Exchange-Traded Fund Trust | 5,77% | 267.267 SH | 21 Ağustos 2026 | Günlük |
| CTIF · EA Series Trust | 3,42% | 71.816 NS | 29 Mayıs 2026 | N-PORT |
| IYH · iShares Trust | 3,05% | 1.033.684 SH | 21 Ağustos 2026 | Günlük |
| SCHD · SCHWAB STRATEGIC TRUST | 2,96% | 32.820.222 NS | 31 Mayıs 2026 | N-PORT |
| CWS · AdvisorShares Trust | 2,95% | 43.046 NS | 30 Haziran 2026 | N-PORT |
| HRTS · Tema ETF Trust | 2,61% | 15.809 NS | 31 Mayıs 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 2,55% | 801.594 NS | 30 Nisan 2026 | N-PORT |
| IXJ · iShares Trust | 2,40% | 915.890 SH | 21 Ağustos 2026 | Günlük |
| HDV · iShares Trust | 2,39% | 3.218.623 SH | 21 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 2,33% | 5.235.711 SH | 19 Ağustos 2026 | Günlük |
| QLTY · GMO ETF Trust | 2,29% | 1.204.586 NS | 31 Mayıs 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 2,28% | 34.673 NS | 30 Nisan 2026 | N-PORT |
| RXL · ProShares Trust | 2,15% | 18.132 NS | 31 Mayıs 2026 | N-PORT |
| QUSA · Tidal Trust III | 2,14% | 4.173 NS | 30 Nisan 2026 | N-PORT |
| FDIV · EA Series Trust | 1,95% | 15.623 NS | 30 Nisan 2026 | N-PORT |
| PRVS · Parnassus Funds II | 1,94% | 5.401 NS | 30 Haziran 2026 | N-PORT |
| OUSA · ALPS ETF Trust | 1,92% | 166.396 NS | 31 Mayıs 2026 | N-PORT |
| MDEV · First Trust Exchange-Traded Fund VI | 1,85% | 392 NS | 30 Haziran 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,85% | 133.006 SH | 21 Ağustos 2026 | Günlük |
| JGRW · Trust for Professional Managers | 1,77% | 19.858 NS | 31 Mayıs 2026 | N-PORT |
| PEXL · Pacer Funds Trust | 1,48% | 7.452 NS | 30 Nisan 2026 | N-PORT |
| KNG · First Trust Exchange-Traded Fund IV | 1,42% | 528.786 NS | 30 Nisan 2026 | N-PORT |
| MFSV · MFS Active Exchange Traded Funds Tr… | 1,41% | 78.110 NS | 31 Mayıs 2026 | N-PORT |
| SPXD · DBX ETF Trust | 1,37% | 1.082 NS | 31 Mayıs 2026 | N-PORT |
| NOBL · ProShares Trust | 1,35% | 1.749.432 NS | 31 Mayıs 2026 | N-PORT |
| ANEW · ProShares Trust | 1,32% | 1.196 NS | 31 Mayıs 2026 | N-PORT |
| VALQ · AMERICAN CENTURY ETF TRUST | 1,24% | 50.554 NS | 31 Mayıs 2026 | N-PORT |
| TMDV · ProShares Trust | 1,23% | 633 NS | 31 Mayıs 2026 | N-PORT |
| EQWL · Invesco Exchange-Traded Fund Trust | 1,21% | 296.845 SH | 21 Ağustos 2026 | Günlük |
| DGRO · iShares Trust | 1,17% | 4.472.407 SH | 21 Ağustos 2026 | Günlük |
| SHRY · First Trust Exchange-Traded Fund VI | 1,07% | 1.770 NS | 30 Haziran 2026 | N-PORT |
| DAK · EA Series Trust | 1,05% | 5.270 NS | 29 Mayıs 2026 | N-PORT |
| SNPV · DBX ETF Trust | 1,01% | 27.271 NS | 29 Mayıs 2026 | N-PORT |
| QIDX · Spinnaker ETF Series | 1,01% | 4.283 NS | 30 Nisan 2026 | N-PORT |
| CGCV · Capital Group Conservative Equity E… | 1,00% | 205.102 NS | 31 Mayıs 2026 | N-PORT |
| RDVI · First Trust Exchange-Traded Fund IV | 0,90% | 304.156 NS | 30 Nisan 2026 | N-PORT |
| BSCQ · Invesco Exchange-Traded Self-Indexe… | 0,85% | 29.472.000 | 21 Ağustos 2026 | Günlük |
| WBIG · Absolute Shares Trust | 0,82% | 2.495 NS | 30 Haziran 2026 | N-PORT |
| BIGY · Tidal Trust II | 0,82% | 2.364 NS | 30 Nisan 2026 | N-PORT |
| USMV · iShares Trust | 0,79% | 1.672.210 SH | 21 Ağustos 2026 | Günlük |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,77% | 73.722 NS | 30 Nisan 2026 | N-PORT |
| CGDV · Capital Group Dividend Value ETF | 0,75% | 3.098.502 NS | 31 Mayıs 2026 | N-PORT |
| MGV · VANGUARD WORLD FUND | 0,75% | 1.094.793 SH | 19 Ağustos 2026 | Günlük |
| DIVB · iShares Trust | 0,74% | 123.321 SH | 21 Ağustos 2026 | Günlük |
| IWX · iShares Trust | 0,73% | 255.571 SH | 21 Ağustos 2026 | Günlük |
| CAPE · DoubleLine ETF Trust | 0,72% | 18.972 NS | 30 Haziran 2026 | N-PORT |
| FEUS · FlexShares Trust | 0,72% | 8.721 NS | 30 Nisan 2026 | N-PORT |
| PFM · Invesco Exchange-Traded Fund Trust | 0,71% | 49.763 SH | 21 Ağustos 2026 | Günlük |
| CGDG · Capital Group Dividend Growers ETF | 0,71% | 417.333 NS | 31 Mayıs 2026 | N-PORT |